Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatment

Tuberculosis (TB) and type 2 diabetes mellitus (DM), a major TB risk factor, are both accompanied by marked alterations in metabolic processes. Dissecting the specific metabolic changes induced by disease through metabolomics has shown potential to improve our understanding of relevant pathophysiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrieling, Frank, Alisjahbana, Bachti, Sahiratmadja, Edhyana, van Crevel, Reinout, Harms, Amy C., Hankemeier, Thomas, Ottenhoff, Tom H. M., Joosten, Simone A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904442/
https://www.ncbi.nlm.nih.gov/pubmed/31822686
http://dx.doi.org/10.1038/s41598-019-54983-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904442/
https://www.ncbi.nlm.nih.gov/pubmed/31822686
http://dx.doi.org/10.1038/s41598-019-54983-5

Ejemplares similares